Skip to main contentSkip to navigation
Ovarian Cancer Research Alliance
Research Exchange
Donate

Investigator

Kang Ren

Chinese Academy Of Medical Sciences Peking Union Medical College

KRKang Ren
Collaborators(7)
Wenhui WangShuning JiaoKe HuZihan YanFu-Quan ZhangFuquan ZhangXiaorong Hou
Institutions(2)
Chinese Academy Of Me…Academy Of Medical Sc…

Clinical Trials (1)

NCT05524389Peking Union Medical College Hospital

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

The purpose of this study is to compare the efficacy and toxicity of early stage endometrial cancer based on molecular classification and conventional risk stratification adjuvant therapy decision-making, and to provide high-quality evidence-based medical evidence for individualized adjuvant therapy selection under the guidance of fine stratification system of endometrial cancer.

Links & IDs
0000-0002-6086-2169
Ovarian Cancer Research Alliance

A global leader in the fight against gynecologic cancer

LIVING LAB
Join the Living LabOur TeamGovernance & EthicsSocial Media Toolkit
DISCOVERY LAB
Discovery LabHow It WorksUpcoming WebinarsContribute Data
ABOUT
About OCRAGet InvolvedMake a DonationContact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

PrivacyTermsAccessibility